2020
Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer
Miszczuk MA, Chapiro J, Geschwind JH, Thakur V, Nezami N, Laage-Gaupp F, Kulon M, van Breugel JMM, Fereydooni A, Lin M, Savic LJ, Tegel B, Wahlin T, Funai E, Schlachter T. Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer. Translational Oncology 2020, 13: 100742. PMID: 32092672, PMCID: PMC7036424, DOI: 10.1016/j.tranon.2020.01.003.Peer-Reviewed Original Research
2016
Interventional Radiology
Schlachter T, Chapiro J, Duran R, Tacher V, Zamboni C, Higgins L, Geschwind J. Interventional Radiology. 2016, 842-859. DOI: 10.1002/9781118512104.ch91.Peer-Reviewed Original ResearchTransjugular intrahepatic portosystemic shuntInterventional radiologyBiliary drain placementPercutaneous ablative techniquesPortal pressure gradientSecondary liver cancerCholecystostomy tube placementPercutaneous transhepatic cholangiographyIntrahepatic portosystemic shuntAppropriate patient populationBiliary stent placementInterventional radiology proceduresGastrointestinal decompressionBiliary tractNutritional supportTranshepatic cholangiographyIntraarterial therapyLess painOpen surgeryPortosystemic shuntTube placementPatient populationDrain placementStent placementAblative techniques